Chronic endometritis (CE), defined as the abnormal invasion  of plasma cells within the endometrial stroma, has been one of the most  investigated conditions.
    Recent studies based on molecular biology-based methods and  endometrial culture showed that chronic endometritis was often associated with  an abnormal endometrial microbiome, with the local proliferation of common  gram-positive (i.e., streptococci, staphylococci) or gram-negative (i.e.,  Escherichia coli, Klebsiella pneumoniae, Neisseria gonorrhoeae) or less common  intracellular (Mycoplasmi, Ureaplasmi, Chlamydiae) or anaerobic  (bifidobacteria, Prevotella) bacteria. 
     
    The randomized controlled trial by Song et al. brought to  light the potential effectiveness of empiric double-regimen oral antibiotic  therapy (i.e., levofloxacin 500 mg and tinidazole 1,000 mg daily for 14 days)  for Chronic endometritis cure. "This was the first study studying the effects of  antibiotics for endometritis treatment with even blinding of pathologists" as illustrated by author.
    Interestingly, the investigators found "CE test  negative rate was 89.3% after a single course of antibiotics in the treatment  arm compared with 12.7% in the control group.In particular, levofloxacin would be active against most  gram-positive and gram-negative bacteria including streptococci, staphylococci,  and Enterobacteriaceae. Tinidazole would provide coverage for most  intracellular and anaerobic bacteria includingUreaplasma, Mycoplasma, and  bifidobacteria. On this basis, the combination of levofloxacin and tinidazole  may offer appropriate antibiotic coverage against most pathogens involved in  CE."
    However, the increased use of antibiotics, especially  quinolones cites a concern for possible increase in antibiotic resistance in  individuals.
    In order to avoid the situation, another recent retrospective  case-control study was conducted that evaluated the effectiveness of a personalized,  antibiogram-guided antibiotic treatment. "The approach led to a cumulative cure  rate of 81.3% after 3 antibiotic cycles, which was inferior to the success rate  of empiric therapy in the study by Song et al. (89.3% after a single antibiotic  cycle)".
    Cons of the study :
    - The treatment arm did not experience a  significant improvement in the conception rate at 12 months follow-up
 - Additionally, among subjects who attempted  pregnancy, the investigators found no difference between groups in terms of  ongoing pregnancy rate and miscarriage rate 
 - The diagnosis of chronic endometritis relied on  the immunohistochemical detection of plasma cells in endometrial biopsy  specimens. Given the blind nature of the endometrial sampling in the study by  Song et al. (i.e., endometrial curettage), a certain bias in the estimates of  CE cure was implicit
 
    Song et al.  provided a new evidence from a randomized, controlled trial about the  effectiveness of empiric, broad-spectrum antibiotic therapy for chronic  endometritis as published in Fertility and sterility journal
    Nonetheless, some issues within the study limit the  conclusions that can be drawn about the impact of chronic endometritis and its  treatment on female fertility. While appropriate antibiotic regimens may  definitely cure CE, the understanding of the relationship between CE therapy  and female fertility appears a more challenging matter.
 
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.